Zobrazeno 1 - 10
of 26
pro vyhledávání: ''
Publikováno v:
Hepatogastroenterology. 58:1291-1295
Background/aims Elimination of chronic viral infection with lamivudine (LAM) has recently been proposed to induce remission of HBV-associated glomerulonephritis (GN). However, prolonged LAM therapy can lead to the development of LAM-resistant HBV, ca
Publikováno v:
Hepatogastroenterology. 58:1301-1306
BACKGROUND/AIMS Serum gamma-glutamyltranspeptidase (GGT) levels often increase in chronic hepatitis C. We aimed to identify whether GGT levels can predict sustained virological response (SVR) in patients with chronic hepatitis C and to investigate ot
Publikováno v:
Hepatogastroenterology.
Background/Aims: Cimetidine has been shown to play an important role in the treatment of cancer and the regulation of the immune system. Therefore, we aimed to observe the effects of cimetidine on the systematic immune response in the perioperative p
Publikováno v:
Hepatogastroenterology.
Background/Aims: This study evaluates the efficacy and safety of trastuzumab combined with docetaxel-based chemotherapy in previously treated metastatic gastric carcinoma of Chinese patients with HER2 over-expression. Methodology: Twenty-two metastat
Publikováno v:
Hepatogastroenterology.
BACKGROUND/AIMS To investigate the role of Kit67, p53, topoisomerase II (TopoII) and glutathione S-transferase P1 (GSTP1) in predicting clinical outcome of advanced gastric cancer patients receiving capecitabine plus paclitaxel chemotherapy. METHODOL
Publikováno v:
Hepatogastroenterology.
BACKGROUND/AIMS For patients with metastatic colorectal cancer, both FOLFOX regimen and FOLFIRI regimen are considered as first-line choices. There are no clinically useful markers that could predict the response to these regimens respectively. We ai
Autor:
Hitoshi Mochizuki, Fumihiko Iwamoto, Seiichiro Takahashi, Syoji Yagawa, Nobuyuki Enomoto, Sumio Hirose, Takashi Yoshida, Kuniaki Shindou, Yuya Tsukui, Kazuhiko Hosoda, Masao Omata, Masanori Matsuda, Kenji Hosoda, Takahisa Yamazaki, Masashi Kobayashi, Toshiyuki Konishi, Youji Suzuki, Akio Tawara, Toru Kuno, Yuichiro Kojima, Satoshi Kawakami, Yoshimitsu Fukasawa, Yuichi Hirose, Yuji Hoshino, Hideki Fujii
Publikováno v:
Hepatogastroenterology.
Background/aims In both SHARP and Asia-Pacific Study, sorafenib was proved to improve the overall survival of the patients with hepatocellular carcinoma. However, factors contributing to the improvement of overall survival of the patients treated by
Autor:
Taner Orug, Sevil Isik, Pars Tunçyürek, Ali Eba Demirbağ, Sezai Yilmaz, Fuat Atalay, Neslihan Inci Zengin
Publikováno v:
Hepatogastroenterology. 59
BACKGROUND/AIMS Hepatic ischemia-reperfusion injury is a major problem in liver surgery. To modulate the complex process of inflammation, additional drugs to add to well-defined organ preserving solutions have been sought. The aim of the current stud
Publikováno v:
Hepatogastroenterology.
BACKGROUND/AIMS This study aims to investigate the influence of endostatin on angiogenesis in hepatocellular carcinoma (HCC) after transarterial chemoembolization (TACE). METHODOLOGY Ninety-five patients with HCC were enrolled. Twenty-six patients re
Autor:
Hideo Kunimoto, Daisuke Morihara, Genryu Hirano, Shu-ichi Ueda, Masaharu Sakamoto, Kaoru Yotsumoto, Keiji Yokoyama, Satoshi Shakado, Kunitoshi Sakurai, Makoto Irie, Hideyuki Iwashita, Shotaro Sakisaka, Kaoru Iwata, Atsushi Fukunaga, Yasuaki Takeyama, Tetsuro Sohda
Publikováno v:
Hepatogastroenterology.
BACKGROUND/AIMS We have evaluated the effectiveness of systemic chemotherapy for patients with extrahepatic metastasis from hepatocellular carcinoma. METHODOLOGY We examined the background, survival rates, median survival time and side effects of 15